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School of Medicine, Tokyo, JapanABSTRACT The calcium-activated slow afterhyperpolarization (sAHP) is a potassium conductance implicated in many phys-
iological functions of the brain including memory, aging, and epilepsy. In large part, the sAHP’s importance stems from its
exceedingly long-lasting time-course, which integrates action potential-induced calcium signals and allows the sAHP to control
neuronal excitability and prevent runaway firing. Despite its role in neuronal physiology, the molecular mechanisms that give rise
to its unique kinetics are, to our knowledge, still unknown. Recently, we identified KCNQ channels as a candidate potassium
channel family that can contribute to the sAHP. Here, we test whether KCNQ channels shape the sAHP rise and decay kinetics
in wild-type mice and mice lacking Hippocalcin, the putative sAHP calcium sensor. Application of retigabine to speed KCNQ
channel activation accelerated the rise of the CA3 pyramidal neuron sAHP current in both wild-type and Hippocalcin knockout
mice, indicating that the gating of KCNQ channels limits the sAHP activation. Interestingly, we found that the decay of the sAHP
was prolonged in Hippocalcin knockout mice, and that the decay was sensitive to retigabine modulation, unlike in wild-type mice.
Together, our results demonstrate that sAHP activation in CA3 pyramidal neurons is critically dependent on KCNQ channel
kinetics whereas the identity of the sAHP calcium sensor determines whether KCNQ channel kinetics also limit the sAHP decay.INTRODUCTIONIn the brain, calcium-dependent potassium channels
tune neuronal excitability and prevent aberrant activity.
Hippocampal pyramidal neurons express members of three
different calcium-activated potassium channel families:
large-conductance calcium-dependent potassium channels
(BK channels), small conductance calcium-activated potas-
sium channels (SK channels), and calcium-activated slow
afterhyperpolarization potassium channels (sAHP) (1–3).
Although all three families play important roles in brain
physiology, the sAHP in particular has also been implicated
in learning and memory, aging, Alzheimer’s disease, and
epilepsy (4–6). Activated in response to high-frequency
neuronal firing or paroxysmal depolarization, the sAHP
acts as a feedback mechanism to prevent runaway neuronal
activity. Unlike the BK and SK channels, the molecular
underpinnings of the sAHP, its mechanism of activation,
and the basis of its unique biophysical properties have
remained controversial since its characterization over
30 years ago (7).
The hallmark of the sAHP is its exceptionally slow
activation and decay kinetics (1,3) that are on the order of
hundreds of milliseconds (rise) and seconds (decay). Several
studies have suggested that this slow time-course is
critical for the role of the sAHP in synaptic plasticity,
spike frequency adaptation, and network synchronization
(8–11). Recent studies have suggested that the sAHP time-
course might be due to the properties of the sAHP diffusible
calcium sensor whereas earlier modeling work had proposedSubmitted June 15, 2012, and accepted for publication November 1, 2012.
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gating kinetics (12–16). However, these proposals have
not been tested directly because the molecular components
of the sAHP were unknown. The recent demonstration that
KCNQ potassium channels contribute to the sAHP current
(IsAHP) in hippocampal CA3 pyramidal neurons (17,18),
and the identification of Hippocalcin, a diffusible neuronal
calcium sensor of the VILIP family, as a sAHP calcium
sensor in pyramidal neurons, have made it possible to test
these models (14,19).
In this work, we make use of these two molecular targets
to investigate the mechanisms underlying the slow sAHP
time-course in CA3 pyramidal neurons. We used KCNQ-
specific pharmacology to test the role of KCNQ channels
in both wild-type and Hippocalcin null CA3 pyramidal
neurons. Our results show that the IsAHP rise is limited
by the KCNQ channel kinetics in both wild-type and
Hippocalcin knockout mice. Unexpectedly, we also find
that the identity of the IsAHP calcium sensor determines
the contribution of KCNQ channel kinetics to the IsAHP
decay because application of retigabine, a KCNQ channel
activator, accelerated the IsAHP decay in Hippocalcin null
neurons, but not in wild-type neurons. Thus, the extent
to which the KCNQ channel kinetics contributes to
the sAHP time-course is dependent upon the identity of
the calcium sensor that gates the sAHP.MATERIALS AND METHODS
Animals
Experiments were carried out according to the guidelines of the University
of Connecticut-Storrs Institutional Animal Care and Use Committee. Bothhttp://dx.doi.org/10.1016/j.bpj.2012.11.002
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maintained by either breeding HC/ males with HC/ females or
breeding HCþ/ males with HCþ/ females. The HC/ mice have been
backcrossed to a C57Bl/6 background for 11–12 generations.PCR genotyping
PCR genotyping of the mouse tail prep DNA was performed as described
previously in Tzingounis et al. (14).Slice preparation and electrophysiology
Transverse hippocampal slices (300 mm) were prepared from 12 to
22 day-old mice. After animals were deeply anesthetized with isoflurane,
they were rapidly decapitated, and the hippocampus was dissected out.
The hippocampus was then secured with glue to the stage of a micron
vibroslicer in ice-cold cutting solution containing 26 mM NaHCO3,
210 mM sucrose, 10 mM glucose, 2.5 mM KCl, 1.25 mM NaH2PO4,
0.5 mM CaCl2, and 7 mM MgCl2. After slicing of the hippocampus, slices
were placed in a storage chamber containing artificial cerebrospinal fluid
(ACSF): 119 mM NaCl, 2.5 mM KCl, 1.3 mM MgCl2, 2.5 mM CaCl2,
1 mM NaH2PO4, 26 mM NaHCO3, 10 mM glucose, equilibrated with
95% O2 and 5% CO2. Slices were maintained at 35
C (30–40 min) and
then at room temperature in a storage chamber that was continuously
perfused with ACSF for at least 1.5 h before recordings. For all recordings,
we perfused slices in the storage ACSF with the addition of 2–10 mM
CNQX (IC50: 40 nM) to block fast synaptic transmission. With the ex-
ception of SK channel experiments seen later in Fig. 4, the recording
ACSF also included 100-nM apamin to block SK channels (IC50: 10–
100 pM). In a subset of experiments, 100-mM picrotoxin was also used to
inhibit GABAA receptors, but we did not see any differences between cells
recorded with or without picrotoxin. Therefore, the majority of our record-
ings took place in the absence of picrotoxin.
Whole-cell recordings were made with infrared differential interference
contrast optics using a 40 water-immersion objective on an upright
microscope (model No. BX51W; Olympus, Melville, NY). Pipettes with
resistances of 3–5 MU were filled with an intracellular pipette solution
containing 130 mM potassium methylsulfate, 10 mM KCl, 10 mM
HEPES, 4 mM NaCl, 4 mM Mg2ATP, 0.4 mM Na4GTP, and 20 mM
myo-inositol (20). Osmolarity was adjusted to 295–300 mOsm and
pH to 7.25–7.35 with KOH. All recordings were from pyramidal neurons
located in the CA3b area of the hippocampus (21) with an initial resting
membrane potential <55 mV. Voltage or current responses were
collected with a Multiclamp 700B (Molecular Devices, Sunnyvale, CA),
filtered at 2 kHz, digitized at 10–50 kHz and analyzed online using
the softwares IgorPro (WaveMetrics, Lake Oswego, OR), Clampfit
(Molecular Devices), or AxoGraph X (AxoGraph Scientific, Queensland,
Australia).
In voltage-clamp recordings, the series resistance was measured by the
instantaneous current response to a 4-mV (100-ms) step with only the
pipette capacitance canceled. The series resistance was measured continu-
ously with recordings being discarded if it changed >20%. Recordings
were not adjusted for the junction potential (8.6 mV), with the exception
of data presented in Table S1 in the Supporting Material. For all voltage-
clamp recordings, the membrane potential was kept at60 mV by applying
a small DC current as needed. For all voltage-clamp recordings, the
membrane potential was clamped to 55 mV.Drugs and reagents
Chemical reagents were purchased from Sigma-Aldrich (St. Louis, MO)
with the exception of retigabine (Santa Cruz Biotechnologies, Santa
Cruz, CA), ICA-27243 (gift from ICAgen, Durham, NC), tetrapotassium-
BAPTA (Molecular Probes, Eugene, OR), and EGTA (Molecular Probes).Data analysis and statistics
The built-in algorithms of KaleidaGraph 4 (Synergy Software, http://www.
synergy.com/) were used for Student’s t-test statistics (paired or unpaired).
Single-exponential fits to determine the activation and decay times were
carried out with the built-in algorithms of Clampfit (Molecular Devices).
For the weighted decay time-constants in Fig. 1 and seen later in Fig. 5,
the peak IsAHP amplitude was measured and divided by the sAHP charge
integrated across 18 s from the peak IsAHP amplitude.RESULTS
KCNQ channel kinetics govern the sAHP current
activation
If KCNQ gating kinetics contribute to the prolonged
kinetics of the IsAHP, a compound that alters the kinetics
of KCNQ channels should alter the IsAHP time-course.
Retigabine is an allosteric KCNQ channel activator that
increases the KCNQ channel open probability and shifts
the KCNQ channel voltage-dependence toward more
hyperpolarized membrane potentials. Importantly, work in
heterologous cells shows that retigabine speeds the activa-
tion kinetics of KCNQ channels (22,23). If KCNQ gating
kinetics determine the IsAHP time-course, retigabine will
alter the IsAHP time-course. We recorded the IsAHP in
CA3b pyramidal neurons from wild-type mice in the pres-
ence of 100 nM apamin to block SK channels (21). To
induce the IsAHP we held cells at 55 mVand gave a brief
depolarization step (100 ms, þ45 mV) to open voltage-acti-
vated calcium channels. Upon return to 55 mV, a slow
activating and decaying sAHP current developed. Bath
application of 40 mM retigabine, a saturating concentration,
significantly accelerated the rise time of the IsAHP (trise ¼
1915 9 ms; trise-ret ¼ 1535 11 ms, n ¼ 7; p < 0.01; see
Fig. 1 a), suggesting that KCNQ channel kinetics limit the
time-course of the sAHP current activation. In contrast,
we found that retigabine had no effect on the IsAHP decay
time-course (tw-decay ¼ 6.6 5 0.3 s; tw-decay-ret ¼ 6.2 5
0.5 s, n ¼ 7; see Fig. 1 a), suggesting KCNQ channel
kinetics are not a determinant of the IsAHP decay.
To further test the idea that KCNQ channel kinetics limit
IsAHP rise kinetics, we repeated the retigabine application
experiments in the presence of the calcium chelator BAPTA
(0.5 mM) (Fig. 1 b). In the presence of 0.5 mM BAPTA, the
rise of the IsAHP is significantly prolonged, presumably due
to the slow calcium exchange between BAPTA and the
IsAHP diffusible calcium sensors (trise ¼ 197 5 16 ms,
n¼ 6; trise-BAPTA¼ 5315 34 ms, n¼ 6; p< 0.01). BAPTA
binds incoming calcium quickly (Kon ~10
8 M1 s1) and
thus competes effectively with endogenous calcium sensors.
As incoming calcium ions equilibrate, calcium is transferred
to the sAHP sensors with BAPTA acting as the calcium
source (13,24,25). This slow exchange of calcium from
BAPTA should limit the IsAHP activation in BAPTA-loaded
neurons, and thus diminish any role of KCNQ channels
kinetics. Consistent with this hypothesis, application ofBiophysical Journal 103(12) 2446–2454
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FIGURE 1 The IsAHP activation depends on KCNQ channel kinetics. (a1) Superimposed normalized IsAHP traces before (black) and after (red) appli-
cation of 40 mM retigabine. (a2) Summarized data showing the effect of retigabine on the IsAHP activation and decay time constants (n ¼ 6, *p < 0.01
Student’s t-test). (b1) Superimposed normalized IsAHP traces before (black) and after (red) application of 40 mM retigabine in neurons loaded with
0.5 mM BAPTA. (b2) Summarized data showing the effect of retigabine on the IsAHP activation and decay time-constants in neurons loaded with
0.5 mM BAPTA (n¼ 5). (c1) Superimposed normalized IsAHP traces before (black) and after (red) application of 20 mM ICA27243. (c2) Summary showing
the effect of ICA27243 on the activation and decay time-constants (n ¼ 5). All recordings were in the presence of 100-nM apamin.
2448 Kim et al.retigabine to BAPTA-loaded neurons no longer accelerated
the IsAHP activation kinetics (trise ¼ 540 5 35 ms;
trise-ret ¼ 6605 94 ms, n ¼ 5; p ¼ 0.2; see Fig. 1 b).
The lack of effect of retigabine in BAPTA-loaded neurons
was not due to failure of retigabine to activate KCNQ
channels. This is because retigabine application induced a
holding current change in BAPTA-loaded neurons of a
similar magnitude to that in BAPTA-free conditions
(0 mM BAPTA, Iret-holding: 173 5 18 pA, n ¼ 7; 0.5 mM
BAPTA, Iret-holding: 168 5 23 pA, n ¼ 5; p ¼ 0.9).Biophysical Journal 103(12) 2446–2454We also tested the effects of a different KCNQ channel
allosteric activator, ICA-27243 (20 mM; see Fig. 1 c, and
see (26,27)). Similar to retigabine, ICA-27243 increases
KCNQ channels’ open probability and induces a leftward
shift in their voltage-dependence. However, work in heterol-
ogous cells has shown that, unlike retigabine, ICA-27243
does not interfere with the KCNQ2/3 or KCNQ5 channel
activation time-course (26,27). Bath application of ICA-
27243 increased the holding current due to KCNQ channel
opening (IICA-holding: 101 5 11 pA, n ¼ 6) similar to
Hippocalcin Dictates sAHP Kinetic Properties 2449retigabine, but differed in that it had no significant effect on
the IsAHP activation kinetics (trise ¼ 210 5 16 ms; trise-
ica ¼ 2275 20 ms, n ¼ 5; p ¼ 0.13; see Fig. 1 c). Together,
these data strongly suggest that the IsAHP activation is
limited by the KCNQ channel kinetics in CA3 pyramidal
neurons.Hippocalcin is the primary sAHP calcium sensor
in CA3 pyramidal neurons
The lack of retigabine’s effect on the sAHP decay suggested
that other factors are responsible for this part of the IsAHP
time-course. A likely candidate is the sAHP calcium sensor,
and consequently, we tested the role of Hippocalcin in
the IsAHP time-course. As there are no pharmacological
blockers for Hippocalcin, we used Hippocalcin knockout
mice (28).
We first determined whether Hippocalcin acts as the
principal sAHP calcium sensor in CA3 pyramidal neurons.
To do this, we compared the magnitude of both the sAHP
and IsAHP between wild-type and Hippocalcin knockout
mice. We recorded the sAHP in current-clamp by rapidly
depolarizing CA3 pyramidal neurons with a 1-nA current
injection for 100 ms to activate voltage-gated calcium
channels. Using this protocol, an sAHP developed after
the termination of the pulse in both HCþ/þ and HC/
mice (Fig. 2 a). There was a significant reduction of the
sAHP peak response in HC/ mice when compared to
wild-type (HCþ/þ) mice (HCþ/þ: 14.7 5 0.6 mV, n ¼ 22;
HC/: 4.8 5 0.4 mV, n ¼ 22; p < 0.001; see Fig. 2 c).
In the same neurons, we also measured the sAHP current50 pA
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FIGURE 2 Hippocalcin is an sAHP calcium sensor in CA3 pyramidal
neurons. (a) Representative sAHP traces from HCþ/þ (black) and HC/
null neurons (red). (b) Representative IsAHP traces from HCþ/þ (black)
and HC/ null neurons (red). (c) Summarized results showing that the
sAHP and sAHP current is significantly decreased in HC/ mice
(n ¼ 22 each, *p < 0.001 Student’s t-test). All recordings were in the
presence of 100-nM apamin.under voltage-clamp after a 100-ms depolarization
to þ45 mV. Similar to the sAHP measures, the IsAHP
amplitude was also dependent on Hippocalcin (IsAHP
in HCþ/þ: 248 5 13 pA, n ¼ 22; HC/: 109 5 9 pA,
n ¼ 22; p < 0.001; see Fig. 2, b and c).
To increase the sensitivity of our sAHP measurements,
we also compared the responses of HCþ/þ and HC/
mice to 1 s current injections whose amplitude ranged
from 0 pA to 300 pA. In both HCþ/þ and HC/ pyramidal
neurons, a sAHP developed whose magnitude depended on
the injected current (see Fig. S1 in the Supporting Material).
We found a reduction of the sAHP across all current injec-
tions in neurons lacking Hippocalcin (see Fig. S1). Similar
measurements were made in neurons whose excitability
was increased by blocking the D-type potassium current
(see Fig. S1), a conductance that limits the number and
frequency of somatic action potentials in CA3 pyramidal
neurons (29). In the presence of D-type potassium current
blockers, current injections elicited a greater number of
action potentials and a correspondingly larger sAHP in
both wild-type and Hippocalcin knockout mice. Nonethe-
less, the sAHP was still smaller in Hippocalcin knockout
mice compared to wild-type mice (see Fig. S1). The reduc-
tion of the sAHP in Hippocalcin knockout mice was not due
to a reduction of the intrinsic excitability of CA3 pyramidal
neurons (see Fig. S1 and Table S1), as current injections in
Hippocalcin knockout mice elicited more action potentials
than in wild-type controls. Thus, we conclude Hippocalcin
acts as a (I)sAHP calcium sensor in CA3 pyramidal neurons
similarly to CA1 and L5 pyramidal neurons.Hippocalcin determines the role of KCNQ
channels in the IsAHP time-course
We also assessed the role of Hippocalcin in the (I)sAHP
kinetics (Fig. 3). After the termination of a brief stimulation
pulse (100 ms, þ45 mV), HCþ/þ pyramidal neurons devel-
oped an sAHP that activated and decayed with time con-
stants of 223 5 9 ms (n ¼ 22) and 4.6 5 0.1 s (n ¼22),
respectively. In HC/ neurons, the same protocol induced
a smaller amplitude sAHP with significantly slower activa-
tion (trise: 4865 32 ms, n ¼22) and decay kinetics (tdecay:
6.45 0.25 s, n ¼ 22; see Fig. 3, a and b). We found similar
prolonged kinetics for the IsAHP generated in voltage-
clamp (trise: HC
þ/þ: 223 5 9.7 ms, n ¼ 22; HC/:
391 5 24 ms, n ¼ 22, p < 0.001; tdecay: HCþ/þ: 5.04 5
0.1 s, n ¼ 22; HC/: 7.2 5 0.2 s, n ¼ 22, p < 0.001;
see Fig. 3, c and d). Thus, loss of Hippocalcin leads to
slower (I)sAHP activation and decay kinetics, suggesting
that Hippocalcin is critical for the IsAHP time-course.
We considered whether loss of Hippocalcin, a small
cytosolic calcium-binding protein, slows the (I)sAHP
kinetics by altering the neurons’ calcium-handling in such
a way as to prolong the calcium signal. To test this possi-
bility, we made use of calcium-activated SK currents asBiophysical Journal 103(12) 2446–2454
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FIGURE 3 Loss of Hippocalcin slows the (I)sAHP time-course. (a) Superimposed normalized sAHP traces from HCþ/þ (black) and HC/ null neurons
(red). (Inset) sAHP activation on an expanded timescale. (b) Summarized results showing that the sAHP trise and tdecay are slower in HC
/ than HCþ/þ
pyramidal neurons (n ¼ 22 each, *p < 0.001 Student’s t-test). (c) Superimposed normalized IsAHP traces from HCþ/þ (black) and HC/ null neurons
(red). (Inset) IsAHP activation on an expanded timescale. (d) Summarized data depicting that the IsAHP trise and tdecay are slower in HC
/ than HCþ/þ
pyramidal neurons (n ¼ 22 each, *p < 0.001 Student’s t-test). All recordings were in the presence of 100-nM apamin.
2450 Kim et al.a reporter for calcium-handling, as has been done previously
in Sah (30). Although the peak of the I-SK current was
similar in wild-type and Hippocalcin knockout mice
(HCþ/þ I-SK ¼ 162 5 10 pA, n ¼ 23; HC/ I-SK ¼
1845 14 pA, n¼ 23; p¼ 0.2) we found that HC/ neurons
have a larger SK channel charge transfer (HCþ/þ Q-SK ¼
24 5 2 pC, n ¼ 23; HC/ Q-SK ¼ 40 5 4 pC, n ¼ 23;
p < 0.001) due to their significantly slowed decay kinetics
(HCþ/þ I-SK tdecay ¼ 146 5 7 ms, n ¼ 23; HC/ I-SK
tdecay ¼ 214 5 8 ms, n ¼ 23; p < 0.001; see Fig. 4). This
experiment indicated that CA3 pyramidal neurons from
Hippocalcin knockout mice undergo a slower calcium
time-course than control cells, and suggested that this might
explain some or all of their slowed IsAHP kinetics.
The considerably slower IsAHP time-course in
Hippocalcin knockout mice raised the possibility that
KCNQ activation has a diminished contribution to the rise
kinetics in these mice. However, retigabine application
to HC/ neurons accelerated the IsAHP activation, just
as it did in HCþ/þ mice (HC/ trise: 262 5 19 ms,
n ¼ 9; trise-ret: 135 5 20 ms, n ¼ 9; p < 0.001; see
Fig. 5 a). Similar to wild-type mice, ICA-27243 had no
effect on the IsAHP rise kinetics (HC/ trise: 298 5
10 ms, n ¼ 4; trise-ica: 326 5 16 ms, n ¼ 4; p ¼ 0.2;Biophysical Journal 103(12) 2446–2454see Fig. 5 b). Surprisingly, retigabine greatly accelerated
the IsAHP decay time-course in HC/ neurons (HC/
tw-decay: 6.8 5 0.4 s, n ¼ 9; tw-decay-ret: 4.4 5 0.6 s,
n ¼ 9; p < 0.001; see Fig. 5 a), despite having no effect
in HCþ/þ mice. More striking was that in the absence of
Hippocalcin, retigabine accelerated the IsAHP decay to an
even faster time-course than was seen in the HCþ/þ IsAHP
(HCþ/þ tw-decay: 6.2 5 0.5 s, n ¼ 7; HC/ tw-decay-ret:
4.45 0.6 s, n ¼ 9; p < 0.05). Collectively, our data suggest
that KCNQ channels contribute to the slow IsAHP activa-
tion time-course, but whether they limit the IsAHP decay
unexpectedly depends on the identity of the calcium sensor.DISCUSSION
KCNQ channel kinetics and the (I)sAHP
time-course
Although the slow time-course of the (I)sAHP has been
noted for decades, its origin has remained enigmatic.
In early work, it was assumed that calcium interacts
directly with the (I)sAHP potassium channel, and con-
temporaneous modeling studies suggested that slow potas-
sium-channel gating was responsible for the protracted
ab
FIGURE 4 Increased SK channel activity in Hippocalcin null neurons.
To isolate the apamin-sensitive potassium current (I-SK), 100-nM apamin
was bath-applied to produce a complete block of SK channels. Currents
in the presence of apamin were subtracted from those without apamin to
determine the I-SK. (a) Superimposed normalized I-SK from HCþ/þ
(black) and HC/ (red) neurons. (b) Summarized results showing the apa-
min-sensitive charge (Q) and decay time constant from HCþ/þ and HC/
neurons (n ¼ 23 each, *p < 0.001 Student’s t-test).
Hippocalcin Dictates sAHP Kinetic Properties 2451kinetics (12,16,31). Recently, we and others have suggested
that diffusible calcium sensors such as Hippocalcin bind
cytosolic calcium, translocate to the plasma membrane,
and trigger the opening of potassium channels to elicit the
(I)sAHP (13–15,19). This suggested that the calcium
sensors might limit the (I)sAHP time-course. Therefore,
the primary goal of this study was to test whether channel
kinetics can also contribute to the (I)sAHP time-course.
Previously, we have shown that KCNQ channels partly
mediate the IsAHP in CA3 pyramidal neurons (17,18).
Consequently, we assessed the role of KCNQ channels in
the IsAHP kinetics by using the allosteric KCNQ channel-
activator retigabine, which is known to speed KCNQ
channel activation kinetics in heterologous cells (23). We
found that application of retigabine speeded the IsAHP acti-
vation in wild-type neurons, suggesting that KCNQ channel
activation is limiting the IsAHP activation process (Fig. 1).
We further found that the effect of retigabine was more
robust in HC/ neurons; despite their slower IsAHP
time-course, application of retigabine accelerated the
IsAHP in HC/ mice to an even faster time-course than
the time-course it induced in wild-type mice (compare
Figs. 1 and 5). Thus, the simplest explanation to account
for these observations is that KCNQ channels kinetics
contribute to the slow (I)sAHP activation in both wild-
type and HC/ CA3 pyramidal neurons, whereas the iden-
tity of the calcium sensor dictates whether KCNQ channels
are critical for the IsAHP decay.
Our finding that retigabine accelerates the IsAHP decay
exclusively in the Hippocalcin knockout mice suggestedthe unexpected possibility that the identity of the (I)sAHP
calcium sensor determines the composition of the (I)sAHP
channels. CA3 pyramidal neurons express KCNQ2,
KCNQ3, and KCNQ5 channels, all of which could poten-
tially contribute to the (I)sAHP (17,18,32). Considering
that KCNQ3 and KCNQ5 are most susceptible to retigabine
modulation (23,33), it is likely that in HC/ null neurons
KCNQ3 and/or KCNQ5 channels play a larger role in the
(I)sAHP time-course than in wild-type mice, thus leading
to the more robust retigabine effect. Currently, we cannot
determine whether such shift in the (I)sAHP channel
KCNQ subunit composition is due to homeostatic changes
in response to loss of Hippocalcin, or if the remaining
(I)sAHP calcium sensor, whose identity is unknown, specif-
ically targets a different subset of KCNQ channels.
Although our results clearly demonstrate a role for
KCNQ channels in the sAHP time-course, the contribution
of Hippocalcin is less clear. The (I)sAHP in Hippocalcin
knockout mice has significantly slower rise and decay
kinetics, but it appears from our experiments on SK
channels that calcium handling is altered; this most likely
contributes to the slowed time-course. It is also possible
that the altered (I)sAHP channel composition plays a role
in the slower kinetics as different KCNQ channel subunits
have different activation and deactivation rates (23).
Nonetheless, we cannot rule out the possibility that the
properties of the remaining (I)sAHP calcium sensor also
slow down the (I)sAHP kinetics in Hippocalcin knockout
mice. Indeed, although application of retigabine speeds the
IsAHP kinetics, the IsAHP is still slow to activate in its pres-
ence compared with other potassium channels in both wild-
type and HC/ neurons. This might be because retigabine
cannot speed the KCNQ channels any further due to a ceiling
effect, or else because Hippocalcin and other (I)sAHP
calcium sensors bind calcium slowly, contributing to the pro-
longed sAHP activation (13). Supporting this latter sugges-
tion, we found that inclusion of the slow calcium-binding
buffer EGTA in the intracellular solution led to a slower
IsAHP activation time constant in both wild-type and
HC/ mice (HCþ/þ trise: 197 5 15 ms, n ¼ 6; trise-EGTA:
3945 31 ms, n ¼ 6, p < 0.001; HC/ trise: 3585 24 ms,
n¼ 6; trise-EGTA: 5575 39 ms, n¼ 6, p< 0.01; see Fig. S2).
For EGTA to delay the IsAHP activation, it must bind
incoming calcium before Hippocalcin or any other IsAHP
calcium sensor. An IsAHP delay will then develop as
calcium is slowly released by EGTA and then bound by
the IsAHP calcium sensors (25). Thus we would predict
that the (I)sAHP calcium sensors should have a calcium-
binding on-rate no greater than the EGTA binding on-rate
(~106 M1 s1; see also Goldberg et al. (13)) and are
a slow step in the (I)sAHP activation mechanism. Together,
our data suggest that there may be no single rate-limiting
step that generates the exceedingly slow time-course of
the (I)sAHP, but rather that the (I)sAHP kinetics are most
likely a function of both slow calcium-binding to the IsAHPBiophysical Journal 103(12) 2446–2454
a1 a2
b2b1
FIGURE 5 KCNQ channel kinetics determine the IsAHP time-course in Hippocalcin knockout mice. (a1) Superimposed normalized IsAHP traces before
(black) and after (red) application of 40 mM retigabine. (a2) Summary data showing the effect of retigabine on the activation and decay time constants in
HC/ neurons (n ¼ 9, *p < 0.001 Student’s t-test). (b1) Superimposed normalized IsAHP traces before (black) and after (gray) application of 20 mM
ICA27243. (b2) Summarized results showing the effect of ICA27243 on the activation and decay time-constant in HC
/ neurons (n ¼ 4). All recordings
were in the presence of 100-nM apamin.
2452 Kim et al.calcium sensors as well as slow activation kinetics of KCNQ
channels.Molecular diversity of calcium-activated sAHPs
A slow afterhyperpolarization develops following a train of
action potentials in multiple cell types throughout the brain.
Depending on the neuron, membrane potential, frequency,
and number of action potentials, this slow afterhyperpolari-
zation is mediated by Ih channels, K-ATP channels, sodium-
activated potassium channels, and/or calcium-activated
sAHP channels (34–37). Traditionally, the calcium-acti-
vated sAHP has been considered as one molecular entity.
Support for this model has come from the observation
that, independent of the cell type, the calcium-activated
sAHP has a similar time-course; is inhibited by norepineph-
rine through the downstream activation of protein kinase A;
and is insensitive to traditional potassium channel blockers
and toxins (1,31).
However, the recent observation that multiple KCNQ
channels and high-affinity neuronal calcium sensors can
mediate the sAHP suggests that the calcium-activatedBiophysical Journal 103(12) 2446–2454sAHP is more molecularly diverse than originally thought.
Further support for this idea stems from our finding that
retigabine differentially affects the IsAHP decay rate in
wild-type and Hippocalcin knockout mice, suggesting that
multiple channel and calcium sensor combinations could
give rise to a IsAHP. Molecular sAHP diversity is also rein-
forced by the previous findings that the pharmacology of the
sAHP depends on the calcium source that activates it. For
instance, UCL2077, a sAHP inhibitor, robustly blocks the
IsAHP activated by calcium influx through L-type calcium
channels in thalamic neurons, but has little effect when
calcium influx is through T-type calcium channels in the
same thalamic neurons (38). Together, our data suggest
that multiple channels and sensors can give rise to a molec-
ularly diverse (I)sAHP.In vivo implications
Over the past decade, the KCNQ family of potassium
channels has emerged as essential regulators of neuronal
excitability. Mutations in either Kcnq2 or Kcnq3 are associ-
ated with benign familial neonatal convulsions, a form of
Hippocalcin Dictates sAHP Kinetic Properties 2453pediatric epilepsy. Currently, it is thought that KCNQ chan-
nels mediate the M-current (39,40), a potassium con-
ductance that first activates at subthreshold potentials and
increases as neurons approach their action-potential
threshold. Consistent with this function, mice engineered
with decreased KCNQ channel activity have smaller
M-currents (41,42). However, we have also shown that
CA3 pyramidal neurons in mice with reduced KCNQ
levels have an additional reduction of the sAHP current,
the major conductance underlying spike frequency adapta-
tion in the hippocampus. This led us to propose that
KCNQ channels may have a second significant identity in
addition to their role in the M-current: as candidates for
the elusive potassium channels that mediate the sAHP
(17,18). In line with this proposal, we recently found that
the specific sAHP inhibitor UCL2077 is also a blocker of
KCNQ channels (32). Our finding that retigabine, a specific
KCNQ channel activator, modifies the IsAHP kinetics in
wild-type and Hippocalcin null neurons further supports
our proposal that KCNQ channels contribute to the sAHP
in hippocampus.
Additionally, it has now become apparent that not all
KCNQ mutations lead to similar neurological deficits. For
instance, a different set of Kcnq2 channel mutations leads
to benign familial neonatal convulsions, whereas another
set leads to epileptic encephalopathy and Ohtahara
syndrome (43,44). It is therefore possible that various
Kcnq channel gating mutations differentially affect the
M-current and sAHP, thus leading to a spectrum of neuro-
logical disorder severity. Lastly, a reliance of the sAHP acti-
vation on KCNQ channel kinetics would make the sAHP
time-course less susceptible to calcium level fluctuations.
As a result, changes in calcium levels as seen during aging
or neurodegenerative disorders like prion disease (45)
would primarily affect the sAHP amplitude but not neces-
sarily its time-course. This is particularly important, as the
sAHP time-course is critical for the development of spike
frequency adaptation, a quiescence period that neurons enter
after a surge of activity.CONCLUSION
In this study, we combined KCNQ-specific pharmacology
to investigate the relative contribution of KCNQ channel
kinetics to the sAHP time-course in CA3 pyramidal
neurons. We found that KCNQ channel kinetics limit the
(I)sAHP activation and that the identity of the sAHP
calcium sensor dictates the extent that KCNQ channel
kinetics contribute to the IsAHP time-course. Overall,
we propose a model in which the sAHP time-course is
controlled by two events—slow calcium binding to a dif-
fusible sensor, followed by the slow activation of KCNQ
channels. Our work provides the first, to our knowledge,
evidence for a role of KCNQ channel kinetics in the
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